Factors associated with remaining on initial randomized efavirenz-containing regimens.

Publication Type:

Journal Article

Source:

AIDS (London, England), Volume 27, Issue 12, p.1887-97 (2013)

Keywords:

2013, August 2013, Vaccine and Infectious Disease Division

Abstract:

Efavirenz (EFV) along with two nucleoside reverse transcriptase inhibitors (NRTIs) is a recommended initial antiretroviral regimen. Understanding characteristics related to EFV success is clinically useful.